VOYA Investment Management
RAPP

VOYA Investment Management’s Rapport Therapeutics RAPP Stock Holding History

VOYA Investment Management’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Sell
58,537
-14,411
-20% -$530K ﹤0.01% 1151
2026
Q1 		$2.28M Buy
72,948
+6,799
+10% +$191K ﹤0.01% 1117
2025
Q4 		$2.01M Buy
66,149
+52,808
+396% +$1.46M ﹤0.01% 1214
2025
Q3 		$396K Buy
+13,341
New +$238K ﹤0.01% 1873

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $498M AUM 267.53% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

VOYA Investment Management's RAPP Position: Q2 2026 in Review

VOYA Investment Management reduced its Rapport Therapeutics (RAPP) stake by 20% in Q2 2026, selling an estimated $530K and leaving 58,537 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

VOYA Investment Management first reported a position in RAPP in Q3 2025 and has held it in 4 quarters since. 160 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • VOYA Investment Management held 58,537 shares of Rapport Therapeutics worth $2.44M as of Q2 2026.
  • VOYA Investment Management sold 14,411 Rapport Therapeutics shares in Q2 2026, an estimated $530K.
  • Rapport Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1151 holding.
  • VOYA Investment Management first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 160 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.